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Summary Familial adenomatous polyposis (FAP) is known to be associated with neoplasia of various tissues,
including thyroid carcinoma. Germline mutations of the tumour-suppressor gene APC, responsible for the
predisposition to FAP, may therefore be involved in the pathogenesis of these tumours. In this report the
structure of the APC gene has been investigated in 26 thyroid tumours, at different stages of dedifferentiation,
that were surgically excised from patients with a negative history of FAP. Approximately 35% of the APC
gene coding region, where most of the mutations are clustered, has been analysed by a combination of
single-strand conformation polymorphism and direct sequencing. No significant alterations could be demon-
strated in any sample examined. It is concluded that, at least in patients not affected by FAP, APC gene
abnormalities do not seem to play a relevant role in the pathogenesis of thyroid carcinoma.
In thyroid tumorigenesis the only evidence in favour of the
alteration of tumour-suppressor genes concerns the occur-
rence of p53 mutations, which appear to be restricted to
poorly differentiated and undifferentiated carcinomas of the
thyroid gland (Ito et al., 1992; Nakamura et al., 1992; Don-
ghi et al., 1993; Fagin et al., 1993). Germline mutations of
the tumour-suppressor gene APC, located on the long arm of
chromosome 5, are responsible for the predisposition to
familial adenomatous polyposis (FAP). FAP is an autosomal
dominant disorder characterised by the development, in
young adults, of hundreds to thousands of adenomatous
colonic polyps. FAP may be associated with osteomas,
epidermoid cysts, fibromas and desmoid tumours, as well as
with tumours of other tissues, including the thyroid, out-
lining the clinical picture of Gardner's syndrome (Gardner &
Richards, 1953; Jarvinen & Sipponen, 1986; Jagelman et al.,
1988). Somatic mutations of the APC gene are also con-
sidered to be an early event in the development of sporadic
gastrointestinal tumours (Powell et al., 1992).
The association between FAP and thyroid carcinoma was
first observed in 1949 (Crail, 1949), and since then several
cases have been reported in the literature (Delamarre et al.,
1988; Ono et al., 1991; Bell & Mazzaferri, 1993). The impor-
tance of this association has not been well established, but
the development of a thyroid carcinoma in two sisters
affected by FAP (Camiel et al., 1968), and the high incidence
of thyroid carcinoma observed in two different large series of
patients with FAP (Plail et al., 1987; Bulow et al., 1988), has
suggested that the concurrence of the two diseases may not
have arisen by chance.
In addition, APC has been found to be expressed in nor-
mal as well as in neoplastic human thyroid tissue, in which
multiple forms of specific RNA transcripts have been
detected (Horii et al., 1993; Zeki et al., 1993). Considering all
the above observations, it may be hypothesised that altera-
tions in APC are likely candidates for a pathogenetic role in
thyroid tumorigenesis.
To test this hypothesis, a series of 26 thyroid tumours of
different histological grades were analysed, by using a com-
bination of single-strand conformation polymorphism (SSCP)
and direct sequencing, in the search for structural alterations
in APC.
Patients and methods
Twenty-six female patients, with a mean age of 44.8 years
and a negative clinical history for colorectal as well as for
other gastrointestinal neoplasms, were treated by surgery for
the presence of thyroid neoplasia. Histological diagnosis
revealed the presence of a thyroid carcinoma in 18 cases (13
papillary, three follicular, two anaplastic) and a follicular
adenoma in the remaining eight patients. After surgical re-
moval, the tumoral and the corresponding extratumoral tis-
sues were quickly frozen in liquid nitrogen and stored at
- 80°C.
Genomic DNA was extracted from all thyroid samples by
the standard SDS-proteinase K digestion followed by
phenol-chloroform extraction. Exons 7-10 and portions of
exon 15 (codons 653-751, 998-1,141 and 1,260-1,547),
which represent approximately 35% of the APC coding
sequence and in which about 90% of all APC gene mutations
are clustered (Miyoshi et al., 1992; Nakatsuru et al., 1991),
were amplified by the polymerase chain reaction (PCR) using
primer pairs and incubation conditions previously described
(Miyoshi et al., 1992).
One microlitre of a 1:1,000 dilution of each PCR product
was further amplified in the presence of 1 fiCi of [32P]dCTP
for a total of 28 cycles. Labelled PCR products were diluted
(1:10) in a solution containing 95% deionised formamide,
0.1% bromophenol blue and 0.1% xylene cyanol, and de-
natured at 95°C for 5 min. SSCP analysis was performed by
electrophoresing denatured samples through a non-
denaturing 6% polyacrylamide gel at 10 W constant power at
either 4°C or 24°C in the presence of 5% glycerol (Cama et
al., 1993).
DNA samples showing an abnormal SSCP electrophoretic
profile were further analysed by direct sequencing of PCR
products using the dideoxy chain-termination method
(Kadowaki et al., 1990).
Results and discussion
SSCP analysis of APC sequences showed an altered band
pattern only in one case of multifocal papillary carcinoma
(Figure 1, lane 7). This alteration was observed in the exon
15 region corresponding to codons 1,389-1,547 and was also
present in a different DNA sample obtained from a distinct
focus of the same neoplastic lesion (Figure 1, lane 27). No
alterations in the APC sequence were detected in the thyroid
extratumoral tissue obtained from the same patient (Figure 1,
lane 28) or in non-tumoral specimens from any of the other
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patients (data not shown). Direct sequencing of the two
samples demonstrated, in both cases, the presence of a
guanine to adenine transition at nucleotide position 4,497 of
the APC coding sequence, corresponding to a CG dinucleo-
tide. This nucleotide change, however, represented a silent
mutation since it did not cause any amino acid change in the
primary structure of the APC protein (data not shown). The
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Figure 1 SSCP analysis ofAPC gene exon 15. A portion ofexon
15 of the APC gene (codons 1,389-1,547) was amplified by PCR
and scanned by SSCP for the presence of mutations in 13 papil-
lary (lanes 1-13), three follicular (lanes 14-16) and two anaplas-
tic (lanes 17 and 18) carcinomas and in eight follicular adenomas
(lanes 19-26). In lane 27 is shown the SSCP profile of DNA
extracted from a different focus of the same papillary tumour
shown in lane 7. The altered SSCP pattern (lanes 7 and 27)
reflected a conservative nucleotide substitution that was not pres-
ent in the extratumoral tissue from the same thyroid gland (lane
28) or in two other non-neoplastic samples (lanes 29-30).
remaining samples did not show alterations of the APC gene
in any of the mutation cluster regions analysed (Figure 1).
Since 1949 the concurrence of FAP and thyroid carcinoma
has been observed in 48 cases (Table I). Most of the studies
published have pointed to the fact that thyroid carcinoma
occurs with an unexpectedly high frequency in patients
affected by FAP. Recently, statistical analysis of data
obtained from an English Polyposis Register has indicated
that the risk for a young female affected by FAP of develop-
ing thyroid carcinoma, particularly of the papillary type, is
about 160-fold higher than expected (Plail et al., 1987).
Similar conclusions have been obtained in a Danish popula-
tion of FAP patients in which the risk of developing thyroid
carcinoma has also been estimated to be 100-fold greater
than in the general population (Billow et al., 1988). Thyroid
carcinoma associated with FAP has been more frequently
found in young female patients (F/M = 6.3:1) than sporadic
thyroid carcinoma (F/M = 2-3:1). The thyroid neoplasia has
usually been discovered within 1-7 years after FAP was
diagnosed. Papillary carcinoma represented the predominant
histotype (8.5%) with a 2-fold higher than expected fre-
quency of multifocal lesions (Table I).
The patients with thyroid carcinoma examined in the pre-
sent study were all females, did not show evidence of an
altered bowel function and always had a negative family
Table I Association between familial adenomatous polyposis (FAP) and thyroid carcinoma
(TC)
Reference
Crail (1949)
Ogata et al. (1964)
Raynham & Louw (1966)
Smith (1968)
Camiel et al. (1968)
Smith & Kern (1973)
Alm & Licznersci (1973)
Mathias & Smith (1977)
Keshgegian & Enterline (1978)
Takahashi et al. (1976)
lida et al. (1977)
Ushio et al. (1977)
Harada et al. (1977)
Okamura et al. (1979)
Hamilton et al. (1979)
Miura et al. (1980)
Lee & Mackinnon (1981)
Delamarre et al. (1982)
Thompson et al. (1983)
Schneider et al. (1983)
Masuyama et al. (1986)
Plail et al. (1987)
Piffer (1988)
Delamarre et al. (1988)
Bulow et al. (1988)
van Erpecum et al. (1988)
Herrera et al. (1989)
Ono et al. (1991)
Bell & Mazzaferri (1993)
Sex
M
M
F
M
F
F
F
F
F
F
F
M
M
F
M
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
Ag
TC
24
31
20
29
19
20
19
<30
21
58
26
26
27
22
29
18
27
23
21
24
37
26
22
26
34
23
20
16
34
26
28
55
29
26
19
40
34
27
50
24
,e Histological type of
FAP thyroid carcinoma
24 Papillary
- Adenocarcinoma
20 Unknown (multifocal)
39 Papillary (multifocal)
- Unknown
- Unknown
28 Papillary
29 Papillary (multifocal)
26 Papillary (multifocal)
- Unknown
- Unknown
- Unknown
- Unknown
- Papillary
14 Papillary (multifocal)
- Papillary
- Unknown
- Unknown
- Unknown
- Papillary
- Papillary
17 Papillary
- Papillary
32 Papillary (multifocal)
27 Follicular
22 Papillary (multifocal)
33 Papillary
- Papillary
21 Papillary (multifocal)
19 Papillary (multifocal)
31 Papillary
27 Papillary (multifocal)
20 Unknown (multifocal)
28 Unknown
17 Unknown
24 Follicular (multifocal)
- Papillary
- Unknown
16 Papillary (multifocal)
21 Papillary (multifocal)
17 Papillary
- Papillary
26 Papillary
31 Papillary
23 Follicular
- Papillary
50 Follicular
24 Papillary
Case
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
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history for the presence ofgastrointestinal diseases. Only one
among the 13 cases of papillary thyroid carcinoma was mul-
tifocal. In this case, the occurrence of the same mutation in
DNA extracted from two distinct tumoral foci, localized in
opposite lobes of the same thyroid gland, but not in the
corresponding extratumoral tissue (Figure 1, lane 28), sug-
gested a common clonal origin of the thyroid tumour.
The frequent association between FAP and thyroid car-
cinoma suggests the involvement of common mechanisms in
the pathogenesis of these two diseases. However, the absence
of germline and somatic APC gene defects in our series of 26
thyroid neoplasms, at different stages of dedifferentiation,
suggests that alterations of this tumour-suppressor gene do
not represent a frequent event in thyroid tumorigenesis.
The small number of cases analysed does not allow any
statistically significant conclusion to be drawn, since a low
incidence of APC mutations cannot be ruled out. However,
our results are in agreement with recent unpublished observa-
tions (Varesco et al., 1993; Zeki et al., 1993). SSCP analysis
of a population of 73 benign and malignant thyroid tumours,
performed on a 1,200 bp stretch of exon 15, also failed to
detect any mutation in the APC gene. Only a nucleotide
insertion, leading to a premature stop codon, was identified
in one out of four thyroid carcinoma cell lines examined,
namely the highly undifferentiated ARO carcinoma cells
(Zeki et al., 1993). APC gene mutations were also absent in a
small group of thyroid tumours in which most of the APC
gene coding region was investigated (Varesco et al., 1993).
In conclusion, our own results and those of others,
gathered from a total of more than 100 thyroid tumours,
suggest that APC mutations do not play a pathogenetic role
in thyroid tumorigenesis, at least in patients not affected by
FAP. However, true estimates of the incidence of APC alter-
ations in thyroid tumours will require the collection of
molecular information from a larger number of cases.
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